Physician profile
Lin Li
NPI 1376839951
$1,440.72
in general payments reported to CMS, 2019-2025
13 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $7.64 · 2021: $433 · 2022: $238 · 2023: $92.94 · 2024: $270 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606 · Education: $3.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.69 |
| Education | $3.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $329.31 | 2019-2025 | Lokelma |
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $166.42 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $151.27 | 2019-2021 | |
| Novo Nordisk INC | $141.97 | 2025 | Ozempic |
| Amgen INC. | $124.63 | 2022-2024 | Krystexxa |
| Calliditas Therapeutics US INC. | $67.21 | 2024-2025 | Tarpeyo |
| Travere Therapeutics, INC. | $63.32 | 2020-2025 | |
| Nxstage Medical, INC. | $56.98 | 2021-2025 | Pureflow Sl, Liberty Select Cycler, Nxstage Cartridge Express |
| Horizon Therapeutics Plc | $53.92 | 2021-2023 | |
| Trice Medical, INC. | $38.27 | 2024 | |
| Glaxosmithkline, LLC. | $28.31 | 2021 | |
| Aurinia Pharma U.S., INC. | $19.11 | 2023 | Lupkynis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lin Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.